Journal
Clinical Cancer Research
Publication Date
2-3-2025
Volume
31
Issue
3
First Page
529
Last Page
542
Document Type
Open Access Publication
DOI
10.1158/1078-0432.CCR-24-1591
Rights and Permissions
Altan M, Lopes G, Hiltermann TJN, Govindan R, Villaruz LC, Calvo E, Edelman MJ, Furqan M, Neal J, Felip E, Carlisle JW, Heymach JV, O'Cearbhaill RE, Zauderer M, Chisamore M, Corigliano E, Eleftheriadou I, Zajic S, Jenkins B, Goodison S, Suchindran S, Ramos-Hernandez N, Tarek N, Schoenfeld AJ. Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung Cancer. Clin Cancer Res. 2025 Feb 3;31(3):529-542. doi: 10.1158/1078-0432.CCR-24-1591 This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license. ©2024 The Authors; Published by the American Association for Cancer Research
Recommended Citation
Altan, Mehmet; Govindan, Ramaswamy; and et al., "Safety and tolerability of letetresgene autoleucel (GSK3377794): Pilot studies in patients with advanced non-small cell lung cancer." Clinical Cancer Research. 31, 3. 529 - 542. (2025).
https://digitalcommons.wustl.edu/oa_4/4775
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
